Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also... see more

Recent & Breaking News (NYSE:GSK)

Turing Rejects $100 Million Offer For Daraprim

Benzinga.com  May 10, 2017

How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Perrigo, and BioScrip

PR Newswire May 8, 2017

Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with Their Usual Care

Business Wire May 5, 2017

Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger

Benzinga.com  April 6, 2017

How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Universal Health Services, Shire, and LifePoint Health

PR Newswire March 31, 2017

GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older

PR Newswire March 15, 2017

How The Ultra-Wealthy Are Helping Advance Health And Life Sciences

Benzinga.com  March 10, 2017

GSK's MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype

PR Newswire March 6, 2017

Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma

Business Wire February 23, 2017

Korn Ferry Futurestep Partners with GlaxoSmithKline to Support Talent Acquisition

Business Wire February 21, 2017

How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Pacira Pharma, and Supernus Pharma

PR Newswire February 16, 2017

Adaptimmune confirms GSK Nomination of Second Adaptimmune Target under Strategic Multi-Target Collaboration

GlobeNewswire January 9, 2017

Ionis Pharma's Target Lifted To $68 Following More Favorable Spinraza Ramp Estimates

Benzinga.com  December 29, 2016

Drug Makers Stocks under Scanner -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline

PR Newswire December 20, 2016

Jefferies' 2017 Global Pharma Outlook

Benzinga.com  December 19, 2016

GSK Starts Phase III Study of Once-Daily Closed Triple Combination Therapy FF/UMEC/VI in Patients with Asthma

Business Wire December 19, 2016

What We Know About Trump's Potential Pick To Head The FDA

Benzinga.com  December 12, 2016

Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study

GlobeNewswire December 5, 2016

GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

Business Wire December 2, 2016

Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

Business Wire December 2, 2016